Latest News and Press Releases

Myriad Genetics announces incorporation of its proprietary HRD platform in Illumina’s updated comprehensive gene panel assay, TruSight™ Oncology 500 v2.

Myriad Genetics announced Prequel® Prenatal Screen is now available at eight weeks into pregnancy.

Myriad Genetics announced SneakPeek is now available over the counter in more than 8,800 retail locations.

Highlights Third quarter revenue grew 11% year-over-year to $213 million, driven by Pharmacogenomics (34%) and Prenatal (10%) and progress on payor coverage and revenue cycle initiatives.Third...

Myriad Genetics comments on UnitedHealthcare’s updated medical policy for pharmacogenetic testing

Myriad Genetics, Inc. (NASDAQ: MYGN) will hold its third quarter earnings conference call on Thursday, Nov. 7, 2024 at 4:30 pm ET.

Myriad Genetics announced a strategic partnership with jscreen to advance health equity and genetic testing access.

Myriad Genetics and Flatiron Health partner to make genetic testing more accessible with EMR integration

SALT LAKE CITY, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a series of ongoing research...

SALT LAKE CITY and FREMONT, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Ultima Genomics, Inc., a...